The Implantable Artificial Heart Project
ABIOMED, Inc.
News
Press Conferences
News Releases
Frequently Asked Questions (FAQ)
Images and Diagrams
The AbioCor Replacement Heart
Frequently Asked Questions (FAQ)
Images and Diagrams
The Researchers
Laman A. Gray, Jr., M.D.
Robert D. Dowling, M.D.

News Releases

Media Advisory
March 11, 2002
FOR MORE INFORMATION:
Linda McGinity Jackson,
502-587-4603
Mary Jennings,
502-587-4230
Kathy Keadle,
502-852-7504

World's second AbioCor™ heart patient to meet the press
Surgeons say Tom Christerson continues to improve

LOUISVILLE, Ky. - As Tom Christerson, the world's second AbioCor™ Implantable Replacement Heart patient reaches the six-month milestone, University of Louisville surgeons Laman Gray, M.D., and Rob Dowling, M.D., will introduce him at a press conference at 3:30 p.m. (EST) on March 12. In a landmark surgery at Jewish Hospital on Sept. 13, Tom Christerson became the second person in the world to receive the AbioCor, manufactured by ABIOMED, Inc., of Danvers, Mass.

The event will take place in the Conference Center at the Rudd Heart and Lung Building on the Jewish Hospital Medical Campus. The news conference agenda will include an update by Drs. Gray and Dowling and a question and answer period with Mr. Christerson.

The news conference will be up-linked live via satellite coordinates Ku-Band SBS 6, Transponder 8, Downlink Frequency 11900 MHZ, 74 degrees West, Vertical Downlink Polarity. The audio frequency is 6.20/6.80. The signal will be available from 3:30-4:30 p.m. (EST), Tuesday, March 12.

The news conference will also be webcast at www.heartpioneers.com. For future reference, the press conference will be archived on www.heartpioneers.com.

###


©2001 Jewish Hospital, University of Louisville Health Sciences Center, ABIOMED, Inc.
Jewish Hospital University of Louisville Health Sciences Center